Nucleic acid immunization protects dogs against challenge with virulent canine parvovirus

Vaccine

Volumn 16, Issue 6, 1998, Pages 601-607

  Jiang, Weiwen ^a   Baker, Henry J ^a   Swango, Larry J ^a   Schorr, Joachim ^b   Self, Melissa J ^a   Smith, Bruce F ^a  

^a AUBURN UNIVERSITY   (United States)

^b QIAGEN GMBH   (Germany)

Author keywords

Canine parvovirus; Nucleic acid vaccine; VP1; VP2

Indexed keywords

NUCLEIC ACID; PLASMID DNA; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DOG; EXPRESSION VECTOR; IMMUNITY; IMMUNIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; VIRUS INFECTION;

ANIMALS; ANTIBODIES, VIRAL; CAPSID; CAPSID PROTEINS; CATS; CLONING, MOLECULAR; DOG DISEASES; DOGS; IMMUNOGLOBULIN G; NEUTRALIZATION TESTS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS, CANINE; POLYMERASE CHAIN REACTION; VACCINATION; VACCINES, DNA; VIRULENCE;

EID: 0032053459     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00239-9     Document Type: Article

References (34)

1. 1 Griffiths, E. Assuring the safety and efficacy of DNA vaccine. Ann. N.Y. Acad. Sci. 1996, 772, 164-169.
2. 2 Donnelly, J.J., Ulmer, J.B. and Liu, M.A. Protective efficacy of intramuscular immunization with naked DNA. Ann. N.Y. Acad. Sci. 1996, 772, 40-46.
3. 3 Ulmer, J.B., Donnelly, J.J. and Parker, S.E. et al. Heteologous protection against influenza by injection of DNA encoding a viral protein. Science 1993, 259, 1745-1749.
4. 4 Wang, B., Ugen, K.E. and Srikantan, V. et al. Gene inoculation generates immune response against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 1993, 90, 4156-4160.
5. 5 Xiang, Z.Q., Spitalnik, S., Tran, M., Wunner, W.H., Cheng, J. and Ertl, H.C.J. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 1994, 199, 132-140.
6. 6 Davis, H.L., Michel, M.L. and Whalen, R.G. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Human Molec. Genet. 1993, 11, 1847-1851.
7. 7 Cox, G.J.M., Zamb, T.J. and Babjuk, L.A. Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J. Virol. 1993, 67, 5664-5667.
8. 8 Conry, R.M., LoBuglio, A.F. and Kantor, J. et al. Immune response to a carcinoembryonic antigen polynuleotide vaccine. Cancer Res. 1994, 54, 1164-1168.
9. 9 Martins, L.P., Lau, L.L., Asano, M.S. and Ahmed, R. DNA vaccination against persistent viral infection. J. Virol. 1995, 69, 2574-2582.
10. 10 Appel, M., Scott, F.W. and Carmichael, L.R. Isolation and immunization studies of a canine parvovirus from dogs with haemorrhagic enteritis. Vet. Rec. 1985, 105, 156-159.
11. 11 Britt, J.O. and Howard, E.B. A new panleukopenia-like syndrome in dogs (canine parvovirus enteritis). Pulse 1979, 21, 17
12. 12 Burtonboy, G., Coignoul, F., Delferriere, N. and Pastoret, P.P. Canine hemorrhagic enteritis: detection of viral particles by electron microscopy. Arch. Virol. 1979, 61, 1-11.
13. 13 Siegl, G., Bates, R.C. and Berns, K.I. et al. Characteristics and taxanomy of Parvoviradae. Intervirology 1985, 23, 61-73.
14. 14 Parrish, C.R. Emergence, natural history, and variation of canine, mink, and feline parvoviruses. Adv. Virus Res. 1990, 38, 403-450.
15. 15 Parrish, C.R., Aquadro, C.F. and Carmichael, L.E. Canine host range and a specific epitope map along with variant sequences in the capsid protein gene of canine parvovirus and related feline, mink and raccoon parvoviruses. Virology 1988, 166, 293-307.
16. 16 Truyen, U., Gruenberg, A., Chang, S.F., Obermaier, B., Veijalainen, P. and Parrish, C.P. Evolution of the feline-subgroup parvovirus and the control of canine host range in vivo. J. Virol. 1995, 69, 4702-4710.
17. 17 Paradiso, P.R., Rhode, S.L. III and Singer, I.I. Canine parvovirus: a biochemical and ultrastructural characterization. J. Gen. Virol. 1982, 62, 113-125.
18. 18 Tsao, J., Chapman, M.S. and Agbandje, M. et al. The three-dimensional structure of canine parvovirus and its functional implications. Science 1991, 251, 1456-1464.
19. 19 Turiso, J.A.L., Cortes, E. and Ranz, A, et al. Fine mapping of canine parvovirus B cell epitopes. J. Gen. Virol. 1991, 72, 2445-2456.
20. 20 Schultz, R.D. The challenge of controlling a newly recognized disease: canine parvovirus vaccines. In: IBC International Symposium 1994, 27-28 October, p. 108
21. 21 Larson, L.J. and Shultz, R.D. High titer canine parvovirus vaccine: serologic response and challenge of immunity study. Vet. Med. 1996, 91, 210-218.
22. 22 Smith-Carr, S., Macintire, D.K. and Swango, L.J. Canine Parvovirus. Part I. Pathogenesis and vaccination. Compend. Contin. Educ. Pract. Vet. 1997, 19, 125-133.
23. 23 Turiso, J.A.L., Cortes, E. and Martinez, C. et al. Recombinant vaccine for canine parvovirus in dogs. J. Virol. 1992, 66, 2748-2753.
24. 24 Langeveld, J.P., Casal, J.I. and Osterhaus, A.D. et al. First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs. J. Virol. 1994, 68, 4506-4513.
25. 25 Casal, J.I., Langeveld, J.P. and Cortes, E. et al. Peptide vaccine against canine parvovirus: identification of two neutralizing subsites n the N terminus of VP2 and optimization of the amino acid sequence. J. Virol. 1995, 69, 7274-7277.
26. 26 Carmichael, L.E., Joubert, J.C. and Pollock, R.V. Hemaglutination by canine parvoviruses: serologic studies and diagnostic applications. AJVR 1980, 41, 784-791.
27. 27 Pollock, R.V.H. ano Carmichael, L.E. Maternal derived immunity to canine parvovirus infection: transfer, decline and interference with vaccination. J. Am. Vet. Med. Ass. 1982, 180, 37-42.
28. 28 Meunier, P.C., Cooper, B.J., Appel, M.J.G., Lanieu, M.E. and Slauson, D.O. Pathogenesis of canine parvovirus enteritis: II. Sequential virus distribution and passive immunization studies. Vet. Pathol. 1985, 22, 617-624.
29. 29 Schirmbeck, R., Bohm, W., Ando, K., Chisari, F.V. and Reimann, J. Nucleic acid vaccination primes hepatitis virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. J. Virol. 1995, 69, 5929-5934.
30. 30 Davis, H.L., Schirmbeck, R., Reimann, J. and Whalen, R.G. DNA-mediated immunization in mice induces a potent MHC classl-restricted cytotoxic T lymphocyte response to the hepatitis B envelope protein. Human Gene. Ther. 1995, 6, 1447-1456.
31. 31 Krieg, A.M., Yi, A.K. and Matson. S. et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995, 374, 547-549.
32. 32 Klinman, D.M., Yi, A.K., Beaucage, S.L., Conover, J. and Krieg, A.M. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc. Natl. Acad. Sci. USA 1996, 93, 2879-2883.
33. 33 Cowdery, J.S., Chase, J.H., Yi, A.K. and Krieg, A.M. Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increase the toxicity of lipopolysaccharides. J. Immun. 1996, 156, 4570-4575.
34. 34 Bird, A.P. CpG-rich islands and the function of DNA methylation. Nature 1986, 321, 209-213.